1h Free Analyst Time
The demand for advanced solutions that expedite bone regeneration and integration has propelled bioactive bone graft materials into the forefront of clinical and research agendas. Driven by an aging global population, rising prevalence of trauma and degenerative diseases, and a growing emphasis on minimally invasive procedures, these materials offer the promise of enhanced osteointegration, reduced healing times, and improved patient outcomes. This executive summary distills the current landscape of bioactive bone graft materials, outlining key market forces, emerging technologies, regulatory dynamics, and strategic considerations. By synthesizing cutting-edge research with real-world adoption trends, this overview equips stakeholders-including medical device manufacturers, clinicians, investors, and policy makers-with a clear, actionable perspective on how to navigate and capitalize on evolving opportunities in this critical segment of regenerative medicine.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping the Bone Graft Landscape
Over the past decade, the bone graft landscape has shifted from passive scaffolds toward multifunctional constructs that actively direct cell behavior and modulate immune responses. Innovations in composite formulations have enabled the integration of therapeutic ions, growth factors, and living cells, transforming grafts from inert fillers into biointeractive platforms. Concurrently, 3D printing and advanced fabrication techniques have allowed patient-specific design, improving fit, structural integrity, and surgical workflow. Regulatory agencies are also evolving, with pathways tailored for combination products and additive manufactured implants, accelerating clinical translation for novel grafts.These transformative shifts have expanded applications beyond traditional orthopedic and dental settings into areas such as craniofacial reconstruction and spinal repair. As surgical robotics and intraoperative imaging become standard, practitioners can deploy bioresponsive grafts with unprecedented precision. Moreover, the convergence of digital health and tissue engineering is fostering remote monitoring of healing progression, enabling adaptive treatment protocols. Together, these advancements are redefining expectations for bone regeneration, turning what was once experimental into tomorrow’s standard of care.
Cumulative Impact of United States Tariffs 2025
In 2025, new tariff regimes introduced by the United States government imposed duties on imported bioactive graft precursors and finished products, aiming to bolster domestic manufacturing and protect strategic supply chains. These measures have increased input costs for companies reliant on exotic glass compositions and specialty polymers sourced abroad. As a result, manufacturers are reevaluating production footprints and negotiating revised supply agreements to mitigate margin erosion.While elevated duties initially constrained availability of certain borosilicate and phosphate glass derivatives, they have simultaneously spurred investment in local capacity expansion and process innovation. By incentivizing domestic melt quenching and sol-gel processing operations, the tariffs have accelerated technology transfers and collaborative ventures between U.S. producers and academic centers. Over time, this realignment may reduce dependence on imports, shorten lead times, and enhance quality control-yet in the near term, price pressures on end-users and reimbursement systems are likely to spark strategic reassessments across the value chain.
Key Segmentation Insights Across Multiple Dimensions
A multifaceted segmentation analysis reveals nuanced opportunities and challenges across material types, applications, product forms, end-user settings, fixation methods, compatibility profiles, manufacturing techniques, and biomaterials interactions. When examined by material type, bioactive ceramics encompass calcium phosphate formulations-both apatitic derivatives and tricalcium phosphate-as well as calcium sulfate variants, while bioactive glasses span borosilicate and phosphate chemistries, and biopolymer-based grafts leverage natural and synthetic polymers. Application-wise, demand concentrates in craniomaxillofacial surgery, including chin augmentation and orbital floor procedures, dental uses such as bone augmentation, periodontal defect repair, and sinus lifts, and orthopedic contexts covering joint reconstruction, spinal fusion, and trauma surgery.In terms of product form, granules available in micro or nano sizes predominate, alongside micronized powders and injectable putty formats for minimally invasive delivery. End-users range from ambulatory surgical centers serving dental and orthopedic clinics to private and public hospitals, as well as academic and industry research institutes that drive innovation. Fixation methods include cemented, hybrid, and uncemented strategies-with press-fit and screw-retained constructs gaining traction. Compatibility considerations differentiate materials by their automatized compatibility properties, such as antioxidant or self-setting characteristics, and by their influence on fibroblast-driven cellular responses. Manufacturing techniques from melt quenching and sintering, including fast-firing protocols, to sol-gel processing define scalability and cost profiles. Finally, interactions with existing biomaterials split into osteoconduction, osteoinduction via controlled cellular cascade induction, and osteopromotion, collectively dictating the regenerative potency of grafts.
Key Regional Insights
Regional dynamics underscore divergent growth trajectories and strategic priorities. In the Americas, robust healthcare infrastructure, favorable reimbursement frameworks, and leading research institutions drive rapid adoption of innovative grafts, while domestic manufacturing expansions respond to recent tariff stimuli. The Europe, Middle East & Africa region exhibits regulatory harmonization under CE marking and a growing interest in minimally invasive craniofacial procedures, supported by established orthopedic and dental device clusters. In Asia-Pacific, demand surges amid expanding middle-class populations, rising incidence of osteoporotic fractures, and government-led initiatives to localize production of advanced biomaterials. Partnerships between regional device makers and academic centers further accelerate commercialization of next-generation grafts, positioning the region as a key growth frontier.Key Company Insights and Strategic Initiatives
Leading industry participants are actively shaping the trajectory of bioactive bone graft materials through targeted R&D investments, portfolio diversification, and strategic collaborations. AlloSource and Baxter International Inc. are advancing composite graft formulations and biologic scaffolds, while Biomatlante SAS emphasizes proprietary glass-ceramic composites for craniomaxillofacial applications. Specialist firms like Collagen Matrix, Inc. integrate collagen-based matrices with osteoinductive factors, and DePuy Synthes Companies leverage global distribution to scale ceramic and polymeric offerings.Major medtech firms including Integra LifeSciences, Medtronic, NuVasive, Orthofix Medical and RTI Surgical combine in-house innovation with bolt-on acquisitions to broaden their graft portfolios, whereas niche innovators Kuros Biosciences and Scient'x focus on targeted indications through collaborative codevelopment with academic spin-offs. Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet Holdings, Inc. maintain comprehensive product suites, uniting graft materials, fixation systems, and digital surgical planning tools to deliver end-to-end solutions in orthopedic and dental markets.
Actionable Recommendations for Industry Leaders
To thrive in this dynamic market, industry leaders should prioritize several strategic imperatives. First, invest in manufacturing agility by adopting modular, scalable production platforms-such as additive manufacturing and fast-firing sintering lines-to buffer against supply chain disruptions and tariff fluctuations. Second, deepen clinical engagement through real-world evidence studies and post-market surveillance programs that quantify patient outcomes, cost savings, and procedural efficiencies, thereby reinforcing reimbursement advocacy.Third, accelerate pipeline diversification by integrating emerging compatibility enhancements-such as automated setting and antioxidant functionalities-and by developing tailored formulations for high-growth niches like spinal fusion and sinus lifts. Fourth, pursue value-based partnerships with payers and health systems to align product pricing with demonstrated clinical benefits. Finally, cultivate cross-sector alliances linking biomaterials research teams with digital health and robotics providers, enabling next-generation, data-driven regenerative therapies.
Conclusion: Navigating the Next Wave of Growth
The bioactive bone graft materials market stands at an inflection point where technological innovation, regulatory evolution, and shifting trade policies converge to redefine competitive advantage. Stakeholders who harness emerging fabrication techniques, strengthen localized production, and substantiate clinical value will lead the next wave of adoption. Integrating advanced compatibility features and fostering collaborative ecosystems that unite biomaterials science with digital surgery will unlock new applications and revenue streams.As the market matures, players that demonstrate agility in navigating tariff landscapes, proactively manage supply chain risks, and forge strategic alliances across the value chain will secure sustainable growth. Through a balanced approach that pairs scientific rigor with commercial acumen, organizations can realize the full promise of bioactive grafts to improve patient outcomes and transform standards of care.
Market Segmentation & Coverage
This research report categorizes the Bioactive Bone Graft Materials Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Bioactive Ceramics
- Calcium Phosphate-Based
- Apatises
- Tricalcium Phosphate
- Calcium Sulphate-Based
- Calcium Phosphate-Based
- Bioactive Glass
- Borosilicate Glasses
- Phosphate Glasses
- Biopolymer-Based
- Natural Polymers
- Synthetic Polymers
- Craniomaxillofacial Surgery
- Chin Augmentation
- Orbital Floor Procedures
- Dental Applications
- Bone Augmentation
- Periodontal Defects
- Sinus Lifts
- Orthopedic Surgeries
- Joint Reconstruction
- Spinal Fusion
- Trauma Surgery
- Granules
- Micro Granules
- Nano Granules
- Powder
- Micronized Powder
- Putty
- Injectable Putty
- Ambulatory Surgical Centers
- Dental Clinics
- Orthopedic Clinics
- Hospitals
- Private Hospitals
- Public Hospitals
- Research Institutes
- Cemented Fixation
- Hybrid Fixation
- Uncemented Fixation
- Press-Fit
- Screw Retained
- Automatized Compatibility
- Antioxidant Properties
- Self-Setting Properties
- Fibroblast Activity
- Cellular Response
- Melt Quenching
- Sintering
- Fast Firing
- Sol-Gel Processing
- Osteoconduction
- Osteoinduction
- Cellular Cascade Induction
- Osteopromotion
This research report categorizes the Bioactive Bone Graft Materials Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Bioactive Bone Graft Materials Market to delves into recent significant developments and analyze trends in each of the following companies:
- AlloSource
- Baxter International Inc.
- Biomatlante SAS
- Collagen Matrix, Inc.
- DePuy Synthes Companies (a Johnson & Johnson company)
- Integra LifeSciences Holdings Corporation
- Kuros Biosciences
- Medtronic, Inc.
- NuVasive, Inc.
- Orthofix Medical Inc.
- RTI Surgical Holdings, Inc.
- Scient'x (a subsidiary of Alphatec Holdings, Inc.)
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioactive Bone Graft Materials Market, by Material Type
8.1. Introduction
8.2. Bioactive Ceramics
8.2.1. Calcium Phosphate-Based
8.2.1.1. Apatises
8.2.1.2. Tricalcium Phosphate
8.2.2. Calcium Sulphate-Based
8.3. Bioactive Glass
8.3.1. Borosilicate Glasses
8.3.2. Phosphate Glasses
8.4. Biopolymer-Based
8.4.1. Natural Polymers
8.4.2. Synthetic Polymers
9. Bioactive Bone Graft Materials Market, by Application
9.1. Introduction
9.2. Craniomaxillofacial Surgery
9.2.1. Chin Augmentation
9.2.2. Orbital Floor Procedures
9.3. Dental Applications
9.3.1. Bone Augmentation
9.3.2. Periodontal Defects
9.3.3. Sinus Lifts
9.4. Orthopedic Surgeries
9.4.1. Joint Reconstruction
9.4.2. Spinal Fusion
9.4.3. Trauma Surgery
10. Bioactive Bone Graft Materials Market, by Product Form
10.1. Introduction
10.2. Granules
10.2.1. Micro Granules
10.2.2. Nano Granules
10.3. Powder
10.3.1. Micronized Powder
10.4. Putty
10.4.1. Injectable Putty
11. Bioactive Bone Graft Materials Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Dental Clinics
11.2.2. Orthopedic Clinics
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Research Institutes
12. Bioactive Bone Graft Materials Market, by Fixation Methods
12.1. Introduction
12.2. Cemented Fixation
12.3. Hybrid Fixation
12.4. Uncemented Fixation
12.4.1. Press-Fit
12.4.2. Screw Retained
13. Bioactive Bone Graft Materials Market, by Compatibility
13.1. Introduction
13.2. Automatized Compatibility
13.2.1. Antioxidant Properties
13.2.2. Self-Setting Properties
13.3. Fibroblast Activity
13.3.1. Cellular Response
14. Bioactive Bone Graft Materials Market, by Manufacturing Techniques
14.1. Introduction
14.2. Melt Quenching
14.3. Sintering
14.3.1. Fast Firing
14.4. Sol-Gel Processing
15. Bioactive Bone Graft Materials Market, by Existing Biomaterials Interaction
15.1. Introduction
15.2. Osteoconduction
15.3. Osteoinduction
15.3.1. Cellular Cascade Induction
15.4. Osteopromotion
16. Americas Bioactive Bone Graft Materials Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Bioactive Bone Graft Materials Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Bioactive Bone Graft Materials Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. AlloSource
19.3.2. Baxter International Inc.
19.3.3. Biomatlante SAS
19.3.4. Collagen Matrix, Inc.
19.3.5. DePuy Synthes Companies (a Johnson & Johnson company)
19.3.6. Integra LifeSciences Holdings Corporation
19.3.7. Kuros Biosciences
19.3.8. Medtronic, Inc.
19.3.9. NuVasive, Inc.
19.3.10. Orthofix Medical Inc.
19.3.11. RTI Surgical Holdings, Inc.
19.3.12. Scient'x (a subsidiary of Alphatec Holdings, Inc.)
19.3.13. Stryker Corporation
19.3.14. Wright Medical Group N.V.
19.3.15. Zimmer Biomet Holdings, Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BIOACTIVE BONE GRAFT MATERIALS MARKET MULTI-CURRENCY
FIGURE 2. BIOACTIVE BONE GRAFT MATERIALS MARKET MULTI-LANGUAGE
FIGURE 3. BIOACTIVE BONE GRAFT MATERIALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BIOACTIVE BONE GRAFT MATERIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BIOACTIVE BONE GRAFT MATERIALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOACTIVE BONE GRAFT MATERIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APATISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM SULPHATE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BOROSILICATE GLASSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PHOSPHATE GLASSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CHIN AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORBITAL FLOOR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BONE AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PERIODONTAL DEFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINUS LIFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MICRO GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY NANO GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MICRONIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CEMENTED FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HYBRID FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRESS-FIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SCREW RETAINED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ANTIOXIDANT PROPERTIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SELF-SETTING PROPERTIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CELLULAR RESPONSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MELT QUENCHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FAST FIRING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SOL-GEL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOCONDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CELLULAR CASCADE INDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOPROMOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 161. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 162. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 163. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 164. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 165. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 166. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 168. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 169. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 170. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 171. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 172. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 173. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 174. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 176. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 178. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 179. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 180. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 181. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 182. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 183. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 184. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 185. CANADA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 186. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 189. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 190. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 191. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 193. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 194. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 196. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 197. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 198. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 199. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIXATION METHODS, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY UNCEMENTED FIXATION, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY AUTOMATIZED COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY FIBROBLAST ACTIVITY, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MANUFACTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY SINTERING, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY EXISTING BIOMATERIALS INTERACTION, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY OSTEOINDUCTION, 2018-2030 (USD MILLION)
TABLE 288. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE CERAMICS, 2018-2030 (USD MILLION)
TABLE 290. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE-BASED, 2018-2030 (USD MILLION)
TABLE 291. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOACTIVE GLASS, 2018-2030 (USD MILLION)
TABLE 292. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY BIOPOLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 293. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 295. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 296. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 297. CHINA BIOACTIVE BONE GRAFT MATERIALS MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION
Companies Mentioned
- AlloSource
- Baxter International Inc.
- Biomatlante SAS
- Collagen Matrix, Inc.
- DePuy Synthes Companies (a Johnson & Johnson company)
- Integra LifeSciences Holdings Corporation
- Kuros Biosciences
- Medtronic, Inc.
- NuVasive, Inc.
- Orthofix Medical Inc.
- RTI Surgical Holdings, Inc.
- Scient'x (a subsidiary of Alphatec Holdings, Inc.)
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
Methodology
LOADING...
